Publications
-
Ajanovic S, Garrido-Aguirre J, Baro B, Balanza N, Varo R, Millat-Martínez P, Arias S, Fonollosa J, Perera A, Jordán-García I, Munoz-Almagro C, Bonet E, Crosas-Soler A, Via E, Nafria-Escalera B, García-García JJ and Bassat Q.
How Did the COVID-19 Lockdown Affect Children and Adolescent's Well-Being: Spanish Parents, Children, and Adolescents Respond
Frontiers in public health . 9: 746052-746052. Number of citations: 8
-
Dobaño C, Alonso S, Fernández de Sevilla-Estrach M, Vidal M, Jiménez A, Pons Tomas G, Jairoce C, Melé Casas M, Rubio R, Hernández García M, Ruiz-Olalla G, Girona M, Barrios D, Santano R, Mitchell RA, Puyol L, Mayer L, Chi J, Rodrigo Melero N, Carolis C, Garcia-Miquel A, Bonet-Carne E, Claverol J, Cubells M, Fortuny-Guasch C, Fumadó V, Jou-Munoz C, Munoz-Almagro C, Izquierdo L, Bassat Q, Gratacós E, Aguilar R, García-García JJ, Moncunill G and Jordán-García I.
Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain
BMC MEDICINE . 19(1): 309-309. Number of citations: 11
-
Bosch-Alcaraz A, Alcolea-Monge S, Rocío Fernández Lorenzo, Luna-Castaño P, Belda-Hofheinz S, Falcó Pegueroles A, Piqueras-Rodríguez P, Molina-Gallego I, Potes-Rojas C, Gesti-Senar S, Orozco-Gámez R, Tercero-Cano MC, Saz-Roy MÁ, Jordán-García I, García-Soler P and Tamame-San Antonio M.
Grade of sedation in the critically ill pediatric patient and its correlation with sociodemographic and clinical variables. Multicentre COSAIP study.
enfermeria intensiva . 32(4): 189-197.
-
Alonso S, Alvarez-Lacalle E, Català M, López D, Jordán-García I, García-García JJ, Soriano-Arandes A, Lazcano U, Sallés P, Masats M, Urrutia J, Gatell A, Capdevila R, Soler-Palacin P, Bassat Q and Prats C.
Age-dependency of the Propagation Rate of Coronavirus Disease 2019 Inside School Bubble Groups in Catalonia, Spain
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 40(11): 955-961. Number of citations: 17
-
Bobillo-Perez S, Girona M, Solé-Ribalta A, Guitart-Pardellans C, Felipe-Villalobos A, Hernandez-Platero L, Balaguer-Gargallo M, Cambra-Lasaosa FJ and Jordán-García I.
Infection…what else? The usefulness of procalcitonin in children after cardiac surgery.
PLoS One . 16(10): . Number of citations: 1
-
Penela-Sánchez D, González-de-Audicana J, Armero-Campos G, Henares-Bonilla D, Esteva-Afonso C, Fernández de Sevilla-Estrach M, Ricart S, Jordán-García I, Brotons-de los Reyes P, Cabrerizo M, Munoz-Almagro C and Launes-Montana C.
Lower Respiratory Tract Infection and Genus Enterovirus in Children Requiring Intensive Care: Clinical Manifestations and Impact of Viral Co-Infections
Viruses-Basel . 13(10): 2059. Number of citations: 7
-
Brotons-de los Reyes P, Pérez-Argüello A, Launes-Montana C, FRANCESC TORRENTS GÓMEZ, Subirats MP, Saucedo-Verdes J, Claverol J, García-García JJ, Rodas G, Fumadó V, Jordán-García I, Gratacós E, Bassat Q and Munoz-Almagro C.
Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES . 110: 363-370. Number of citations: 14
-
Deyà-Martinez A, García-García A, Gonzalez-Navarro EA, Luo Y, Vlagea A, Jordán-García I, Fumadó V, Fortuny-Guasch C, Español M, Launes-Montana C, Esteve-Solé A, Juan-Otero M, Pascal M and Alsina L.
COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era
CLINICAL IMMUNOLOGY . 230: 108821-108821. Number of citations: 16
-
Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, HGID Lab, COVID Clinicians, COVID-STORM Clinicians, NIAID Immune Response to COVID Group, NH-COVAIR Study Group, Danish CHGE, Danish Blood Donor Study, St. James's Hospital, SARS CoV2 Interest group, French COVID Cohort Study Group, Imagine COVID-Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19, Biobank Investigators, COVID Human Genetic Effort, CONSTANCES cohort, 3C-Dijon Study, Cerba Health-Care, Etablissement du Sang study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L and Casanova JL.
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Science immunology . 6(62): . Number of citations: 391
-
Brotons-de los Reyes P, Jordán-García I, Bassat Q, Henares-Bonilla D, Fernández de Sevilla-Estrach M, Ajanovic S, Redin-Alonso A, Fumadó V, Baro B, Claverol J, Varo R, Cuadras-Palleja D, Hecht J, Barrabeig I, García-García JJ, Launes-Montana C and Munoz-Almagro C.
The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study
Viruses-Basel . 13(8): 1598. Number of citations: 14